Provided by Tiger Fintech (Singapore) Pte. Ltd.

Charles River Laboratories

154.48
-2.2200-1.42%
Post-market: 154.480.00000.00%16:51 EDT
Volume:493.64K
Turnover:76.44M
Market Cap:7.59B
PE:-249.91
High:158.18
Open:158.01
Low:153.31
Close:156.70
Loading ...

Upslope Capital Management Sold Charles River (CRL) Due to Thesis Break

Insider Monkey
·
22 Apr

Regeneron CRL for Eylea extension not surprising, says Oppenheimer

TIPRANKS
·
21 Apr

Jefferies Adjusts Price Target on Charles River Laboratories International to $100 From $169, Maintains Hold Rating

MT Newswires Live
·
21 Apr

U.S. RESEARCH ROUNDUP-Lowe's, Netflix, Vulcan Materials

Reuters
·
21 Apr

Charles River Laboratories International Inc : Jefferies Cuts Target Price to $100 From $169

THOMSON REUTERS
·
21 Apr

Regeneron Provides Update on EYLEA HD® (aflibercept) Injection 8 mg Supplemental Biologics License Application

GlobeNewswire
·
19 Apr

Charles River Laboratories International, Inc. (CRL): Among Mid-Cap Stocks Insiders Were Buying in Q1 2025

Insider Monkey
·
18 Apr

Baird Adjusts Price Target on Charles River Laboratories International to $118 From $101, Keeps Neutral Rating

MT Newswires Live
·
17 Apr

Charles River price target raised to $118 from $101 at Baird

TIPRANKS
·
17 Apr

Charles River Laboratories International Inc : Baird Raises Target Price to $118 From $101

THOMSON REUTERS
·
17 Apr

Charles River Laboratories International Inc. Stock Outperforms Competitors Despite Losses On The Day

Dow Jones
·
17 Apr

Press Release: Charles River Laboratories Schedules First-Quarter 2025 Earnings Release and Conference Call

Dow Jones
·
16 Apr

Strength Seen in Charles River (CRL): Can Its 6.9% Jump Turn into More Strength?

Zacks
·
15 Apr

Charles River Laboratories International Inc. Stock Rallies 6.9%, Outperforms Competitors

Dow Jones
·
15 Apr

Equity Markets Rise as Investors Respond to Tariff News

MT Newswires Live
·
15 Apr

BUZZ - S&P 500 top and bottom performing stocks at about 12:00 p.m. EDT

Reuters
·
15 Apr

BofA Securities Cuts Charles River Laboratories International Price Target to $150 From $185

MT Newswires Live
·
14 Apr

Deutsche Bank Adjusts Price Target on Charles River Laboratories International to $140 From $210

MT Newswires Live
·
12 Apr

US FDA to Phase Out Animal Testing in Drug Development, Adopt AI Methods

Reuters
·
11 Apr

FDA reducing animal testing presents overhang for Charles River, says TD Cowen

TIPRANKS
·
11 Apr